You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Suppliers and packagers for generic pharmaceutical drug: VARDENAFIL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


VARDENAFIL HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alembic VARDENAFIL HYDROCHLORIDE vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 208324 ANDA Alembic Pharmaceuticals Limited 46708-235-04 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (46708-235-04) 2018-11-20
Alembic VARDENAFIL HYDROCHLORIDE vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 208324 ANDA Alembic Pharmaceuticals Inc. 62332-235-04 4 BLISTER PACK in 1 CARTON (62332-235-04) / 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 2018-11-20
Macleods Pharms Ltd VARDENAFIL HYDROCHLORIDE vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 205988 ANDA Macleods Pharmaceuticals Limited 33342-203-37 1 BLISTER PACK in 1 CARTON (33342-203-37) / 4 TABLET in 1 BLISTER PACK 2018-10-26
Alembic VARDENAFIL HYDROCHLORIDE vardenafil hydrochloride TABLET;ORAL 214031 ANDA Alembic Pharmaceuticals Limited 46708-236-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-236-30) 2020-08-05
Alembic VARDENAFIL HYDROCHLORIDE vardenafil hydrochloride TABLET;ORAL 214031 ANDA Alembic Pharmaceuticals Limited 46708-236-31 100 TABLET, FILM COATED in 1 BOTTLE (46708-236-31) 2020-08-05
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Vardenafil Hydrochloride

Last updated: July 29, 2025


Introduction

Vardenafil hydrochloride is a potent phosphodiesterase type 5 (PDE5) inhibitor primarily prescribed for erectile dysfunction (ED). Its global demand has witnessed steady growth, driven by increasing awareness and acceptance of ED treatments, alongside advancements in formulation and delivery methods. As a critical component, the supply chain for vardenafil hydrochloride involves numerous manufacturers, both reputable pharmaceutical companies and reputable bulk API suppliers that serve global markets.

This report analyzes the leading suppliers of vardenafil hydrochloride, examining their manufacturing capabilities, supply reliability, compliance standards, and strategic positioning within the pharmaceutical API industry.


Global Market Overview of Vardenafil Hydrochloride Suppliers

Vardenafil hydrochloride's manufacturing landscape comprises a combination of innovator companies that develop proprietary formulations and a broad base of generic API producers. The key to success in this market hinges on quality assurance, regulatory compliance, production scalability, and cost competitiveness.

The primary sources of vardenafil hydrochloride can be categorized into branded pharmaceutical manufacturers and bulk API suppliers operating across various regions, notably in Asia, Europe, and North America.


Leading Suppliers of Vardenafil Hydrochloride

1. US and European-Origin Manufacturers

a) European Pharmaceutical Companies

Many European firms specialize in high-quality pharmaceutical APIs, including vardenafil. These companies often adhere to stringent Good Manufacturing Practices (GMP), ensuring compliance with global regulatory standards such as EMA and FDA approvals.

  • Dr. Reddy's Laboratories (India/Europe)
    Dr. Reddy’s is a prominent global pharmaceutical manufacturer that produces vardenafil hydrochloride API, exporting worldwide. Their facilities are GMP-certified, and the company has a long-standing reputation for high quality and consistent supply.

  • Sino Biopharmaceutical Limited (Hong Kong/China)
    While primarily focused on biosimilars, Sino Biopharmaceutical has expanded into various generics, including PDE5 inhibitors, with manufacturing capacity aligned to meet global demand.

b) US-based Suppliers

  • Aurobindo Pharma
    Aurobindo is a leading API producer with substantial expertise in PDE5 inhibitors, including vardenafil. Their U.S. FDA-approved facilities enhance their credibility, especially for clients targeting North American markets.

2. Asian API Manufacturers

a) China-Based Suppliers

China remains a dominant hub for API manufacturing due to cost advantages and manufacturing scale. Key players include:

  • Hangzhou Hisun Pharmaceutical
    Hisun offers high-quality vardenafil hydrochloride API, supported by GMP certification and extensive export experience.

  • Topfond Pharmaceutical
    Specializes in the synthesis of PDE5 inhibitors, providing bulk vardenafil hydrochloride to pharmaceutical companies worldwide.

  • Qingdao Jingyifeng Pharmaceutical
    Recognized for large volume API production, Jingyifeng supplies vardenafil hydrochloride compliant with international standards.

b) Indian API Manufacturers

India's reputation as the "pharmacy of the world" extends to vardenafil API production, with several established companies:

  • Marksans Pharma
    Possesses manufacturing facilities compliant with GMP and supplies vardenafil hydrochloride for generic formulations.

  • Hetero Drugs
    An active supplier of PDE5 inhibitor APIs, including vardenafil, serving both domestic and export markets.

  • Natco Pharma
    Produces high-quality APIs with a growing export footprint, supported by rigorous quality management systems.

3. Other Notable Manufacturers

  • Vivimed Labs (India): Offers a range of pharmaceutical intermediates and APIs, including vardenafil hydrochloride.

  • Cadila Healthcare (India): Growing generic API portfolio with GMP-certified facilities.


Supply Chain Considerations

Quality and Regulatory Compliance

Suppliers with GMP certifications from recognized authorities (FDA, EMA, or local standards) are preferred for global supply chains. Consistent quality assurance minimizes regulatory risks and ensures market acceptance.

Manufacturing Scale and Capacity

Suppliers with large-scale facilities can provide stable, bulk quantities, reducing risks associated with supply shortages. Companies such as Hisun and Aurobindo maintain extensive production capacities, suitable for large pharmaceutical companies and contract manufacturing organizations (CMOs).

Pricing and Cost Competitiveness

Pricing varies based on manufacturing location and scale. Chinese and Indian manufacturers typically offer cost advantages, though regulatory and quality assurance costs must be factored into procurement decisions.

Certification and Documentation

Suppliers offering comprehensive documentation, such as COA (Certificate of Analysis), DSC (Drug Substance Certificate), and compliance certificates, streamline regulatory approval processes in different jurisdictions.


Emerging Trends and Strategic Moves in the Vardenafil Hydrochloride Supplier Landscape

  • Vertical Integration: Several companies integrate API manufacturing with formulation development to streamline supply and reduce costs.

  • Consolidation: Industry consolidation has increased supplier reliability, with larger players acquiring smaller firms to expand capacities and diversify offerings.

  • Focus on Quality: Increasing regulatory scrutiny has led suppliers to invest heavily in quality systems and GMP compliance, serving as differentiating factors.

  • Innovation in Formulation: Some API suppliers are developing novel formulations and delivery systems, providing opportunities for API suppliers to partner with innovative pharma firms.


Conclusion

The procurement of vardenafil hydrochloride necessitates careful evaluation of supplier credentials, production capacity, compliance status, and cost structure. Leading global suppliers predominantly stem from Asia—particularly China and India—owing to their substantial manufacturing expertise and economic advantages. European and North American firms remain critical players, especially for clients prioritizing stringent quality standards and regulatory compliance.

Ensuring a robust supply chain involves selecting suppliers with proven GMP certification, reliable track records, and comprehensive documentation. Strategic partnerships with reputable API manufacturers can help mitigate risks associated with supply interruptions and regulatory hurdles.


Key Takeaways

  • Major suppliers of vardenafil hydrochloride are primarily located in China (e.g., Topfond, Qingdao Jingyifeng) and India (e.g., Aurobindo, Hetero, Natco). European firms like Dr. Reddy's also play a vital role.

  • GMP certification and regulatory compliance are non-negotiable criteria for global supply stability and market acceptance.

  • Supply reliability hinges on capacity, quality assurance systems, and supply chain transparency.

  • Cost competitiveness is significant in Asia, but quality and regulatory credibility often influence supplier selection.

  • Strategic alliances with well-established API manufacturers help ensure supply chain resilience amid geopolitical and market fluctuations.


FAQs

1. What factors should I consider when selecting a vardenafil hydrochloride supplier?
Prioritize GMP certification, consistent quality, adequate manufacturing capacity, transparent documentation, and compliance with international standards.

2. Are Chinese API manufacturers reliable for vardenafil hydrochloride?
Yes, many Chinese suppliers possess GMP certifications and export compliance, making them dependable partners when supplier credentials are verified.

3. How does regulatory compliance affect API supplier selection?
Suppliers with recognized certifications (FDA, EMA) reduce regulatory risks, streamline approval processes, and ensure market access.

4. Is there a difference in quality between branded and generic API suppliers?
Generally, branded API suppliers adhere to stricter quality controls; however, many generic API manufacturers also maintain high standards, especially those with GMP certification.

5. What future trends could impact the supply landscape of vardenafil hydrochloride?
Increasing regulatory scrutiny, industry consolidation, technological advancements in synthesis, and a shift toward vertical integration are shaping the supply dynamics.


Sources:

[1] Market intelligence reports and company disclosures.
[2] Industry analyses on API manufacturing.
[3] Regulatory agencies' directories and certificates.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing